Perceptive Advisors as of March 31, 2019
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 102 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 9.8 | $331M | 3.8M | 88.10 | |
| Amicus Therapeutics (FOLD) | 8.7 | $294M | 22M | 13.60 | |
| Global Blood Therapeutics In | 8.6 | $293M | 5.5M | 52.93 | |
| Zogenix | 6.3 | $213M | 3.9M | 55.01 | |
| Amarin Corporation | 4.0 | $136M | 6.5M | 20.76 | |
| Iovance Biotherapeutics (IOVA) | 3.4 | $116M | 12M | 9.51 | |
| Meiragtx Holdings (MGTX) | 3.1 | $104M | 6.0M | 17.23 | |
| Array BioPharma | 3.0 | $103M | 4.2M | 24.38 | |
| Blueprint Medicines (BPMC) | 3.0 | $102M | 1.3M | 80.05 | |
| Quotient Technology | 2.9 | $97M | 11M | 9.01 | |
| Mirati Therapeutics | 2.5 | $85M | 1.2M | 73.30 | |
| Retrophin | 2.0 | $69M | 3.1M | 22.63 | |
| Regenxbio Inc equity us cm (RGNX) | 1.9 | $66M | 1.1M | 57.31 | |
| Merit Medical Systems (MMSI) | 1.9 | $65M | 1.1M | 61.83 | |
| Arena Pharmaceuticals | 1.9 | $63M | 1.4M | 44.83 | |
| Athenex | 1.8 | $62M | 5.1M | 12.25 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $59M | 2.6M | 22.76 | |
| Cymabay Therapeutics | 1.6 | $56M | 4.2M | 13.28 | |
| Albireo Pharma | 1.6 | $55M | 1.7M | 32.21 | |
| Myokardia | 1.5 | $51M | 989k | 51.99 | |
| Invitae (NVTAQ) | 1.5 | $51M | 2.2M | 23.42 | |
| Allogene Therapeutics (ALLO) | 1.3 | $45M | 1.5M | 28.91 | |
| Vbi Vaccines | 1.3 | $43M | 24M | 1.78 | |
| Momenta Pharmaceuticals | 1.2 | $42M | 2.9M | 14.53 | |
| Verrica Pharmaceuticals | 1.1 | $39M | 3.4M | 11.30 | |
| Viewray (VRAYQ) | 1.1 | $36M | 4.8M | 7.39 | |
| Kadmon Hldgs | 1.0 | $35M | 13M | 2.64 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $34M | 3.2M | 10.75 | |
| Neptune Wellness Solutions I | 0.8 | $28M | 8.9M | 3.19 | |
| Aldeyra Therapeutics (ALDX) | 0.8 | $28M | 3.1M | 9.03 | |
| Dova Pharmaceuticals | 0.8 | $28M | 3.1M | 8.89 | |
| Teladoc (TDOC) | 0.8 | $28M | 495k | 55.60 | |
| Concert Pharmaceuticals I equity | 0.8 | $27M | 2.2M | 12.07 | |
| Nevro (NVRO) | 0.8 | $26M | 417k | 62.51 | |
| Protagonist Therapeutics | 0.8 | $26M | 2.1M | 12.57 | |
| Adma Biologics (ADMA) | 0.7 | $25M | 6.5M | 3.79 | |
| Vapotherm | 0.7 | $25M | 1.2M | 19.65 | |
| Kodiak Sciences (KOD) | 0.6 | $21M | 3.1M | 6.53 | |
| eHealth (EHTH) | 0.5 | $18M | 290k | 62.34 | |
| Foamix Pharmaceuticals | 0.5 | $18M | 4.7M | 3.75 | |
| Eidos Therapeutics | 0.5 | $16M | 687k | 23.45 | |
| Axonics Modulation Technolog (AXNX) | 0.5 | $16M | 686k | 23.95 | |
| Irhythm Technologies (IRTC) | 0.4 | $15M | 200k | 74.96 | |
| Bausch Health Companies (BHC) | 0.4 | $15M | 600k | 24.70 | |
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $15M | 614k | 24.04 | |
| Aquestive Therapeutics | 0.4 | $15M | 2.1M | 6.91 | |
| Uniqure Nv (QURE) | 0.4 | $14M | 232k | 59.65 | |
| Akebia Therapeutics (AKBA) | 0.4 | $14M | 1.7M | 8.19 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $14M | 503k | 27.41 | |
| Mei Pharma | 0.4 | $14M | 4.4M | 3.07 | |
| Marker Therapeutics Ord | 0.4 | $13M | 2.0M | 6.60 | |
| Agile Therapeutics | 0.4 | $13M | 8.4M | 1.51 | |
| Motus Gi Hldgs Incorporated | 0.4 | $13M | 3.2M | 3.90 | |
| Molecular Templates | 0.3 | $12M | 2.0M | 5.81 | |
| Solid Biosciences | 0.3 | $11M | 3.9M | 2.90 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.3 | $10M | 723k | 13.87 | |
| Orchard Therapeutics Plc ads | 0.3 | $9.3M | 522k | 17.88 | |
| Alector (ALEC) | 0.3 | $9.6M | 512k | 18.72 | |
| Humana (HUM) | 0.3 | $9.3M | 35k | 266.00 | |
| Dbv Technologies S A | 0.3 | $8.7M | 1.1M | 7.71 | |
| Urovant Sciences | 0.3 | $8.7M | 865k | 10.05 | |
| Zymeworks | 0.2 | $8.5M | 574k | 14.86 | |
| Ani Pharmaceuticals Inc. note 3.000 12/0 | 0.2 | $8.3M | 7.5M | 1.10 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $8.0M | 458k | 17.54 | |
| Synlogic | 0.2 | $6.6M | 868k | 7.59 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $6.1M | 331k | 18.35 | |
| Shockwave Med | 0.1 | $5.0M | 150k | 33.47 | |
| Sierra Oncology | 0.1 | $4.6M | 2.7M | 1.71 | |
| Translate Bio | 0.1 | $4.4M | 435k | 10.19 | |
| Livanova Plc Ord (LIVN) | 0.1 | $3.9M | 40k | 97.25 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $3.5M | 50k | 69.36 | |
| Intersect Ent | 0.1 | $2.3M | 70k | 32.16 | |
| Abeona Therapeutics Inc *w exp 12/19/201 | 0.1 | $1.9M | 660k | 2.89 | |
| Eiger Biopharmaceuticals | 0.1 | $2.0M | 140k | 13.98 | |
| Female Health (VERU) | 0.1 | $2.1M | 1.4M | 1.46 | |
| Vocera Communications | 0.1 | $1.6M | 50k | 31.64 | |
| Oncomed Pharmaceuticals | 0.1 | $1.8M | 1.7M | 1.04 | |
| Acasti Pharma | 0.1 | $1.8M | 1.8M | 1.02 | |
| CryoLife (AORT) | 0.0 | $1.5M | 50k | 29.18 | |
| Abeona Therapeutics | 0.0 | $1.3M | 181k | 7.36 | |
| Avedro | 0.0 | $1.2M | 100k | 12.27 | |
| Allena Pharmaceuticals | 0.0 | $929k | 132k | 7.02 | |
| Fiat Chrysler Automobiles N | 0.0 | $920k | 62k | 14.84 | |
| Biogen Idec (BIIB) | 0.0 | $620k | 400k | 1.55 | |
| D Fluidigm Corp Del (LAB) | 0.0 | $612k | 46k | 13.30 | |
| Veracyte (VCYT) | 0.0 | $789k | 32k | 25.03 | |
| Ferrari Nv Ord (RACE) | 0.0 | $830k | 6.2k | 133.87 | |
| Axsome Therapeutics (AXSM) | 0.0 | $767k | 54k | 14.24 | |
| Tandem Diabetes Care (TNDM) | 0.0 | $816k | 13k | 63.53 | |
| ACADIA Pharmaceuticals (ACAD) | 0.0 | $400k | 15k | 26.85 | |
| Clovis Oncology | 0.0 | $248k | 400k | 0.62 | |
| Sarepta Therapeutics (SRPT) | 0.0 | $421k | 100k | 4.21 | |
| Biotelemetry | 0.0 | $399k | 6.4k | 62.65 | |
| Fibrogen | 0.0 | $506k | 9.3k | 54.37 | |
| Vericel (VCEL) | 0.0 | $492k | 28k | 17.52 | |
| Evolus (EOLS) | 0.0 | $344k | 15k | 22.58 | |
| ImmunoGen | 0.0 | $12k | 600k | 0.02 | |
| Immunomedics | 0.0 | $124k | 200k | 0.62 | |
| Agios Pharmaceuticals (AGIO) | 0.0 | $140k | 200k | 0.70 | |
| Ascendis Pharma A S (ASND) | 0.0 | $158k | 1.3M | 0.12 | |
| Oncosec Med | 0.0 | $17k | 30k | 0.57 | |
| Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $160k | 421k | 0.38 |
